Objectives. This study was undertaken to investigate the possible association of Fas gene mutation(s) or polymorphism(s) with systemic lupus erythematosus (SLE) in Japanese.
Systemic lupus erythematosus (SLE ) is an inflammatory
and its ligand ( FasL) have been reported in mouse disorder affecting multiple organ systems; it is charactermodels of human SLE: MRL-lpr, MRL-lprcg and C3H-ized by the presence of antibodies reactive against varigld mice [3] [4] [5] . In patients with SLE, increased levels ous self-antigens. The breakdown of self-tolerance in of the soluble form of Fas have been reported which SLE is caused by a defect in the elimination of automay interfere with the apoptosis of autoreactive lymphoreactive T or B cells [1] .
cytes [6] [7] [8] . However, a lack of correlation between Apoptosis (programmed cell death) is a physiological soluble Fas levels and autoimmune diseases has also process that regulates normal tissue homeostasis. Failure been reported [9, 10] . Structural defects in the genes for of apoptosis is likely to contribute to the development Fas and FasL have been identified in humans as well as of autoimmune disorders by the impaired elimination mice. The defects in the Fas gene are identified in the of autoreactive T or B cells. Fas, also known as APO-1 disease known as autoimmune lymphoproliferative synor CD95, is a type I membrane protein and is expressed drome (ALPS ) or Canale-Smith syndrome, which is in various cell types. Fas is considered to play a critical characterized by massive lymphadenopathy, hepatorole in the regulation of the immune system by deleting splenomegaly, and autoimmune manifestations such autoreactive peripheral lymphocytes [2] . Defects in Fas as haemolytic anaemia and thrombocytopenia, with increased peripheral double-negative T cells [11] [12] [13] [14] . In one SLE patient, a defect in FasL was reported to be Submitted 30 September 1998; revised version accepted 25 identify any mutations in the Fas gene with reverse transcriptase-polymerase chain reaction (RT-PCR)/ single-strand conformation polymorphism (SSCP) analysis; however, we identified a novel polymorphism, T297C, which corresponds to the first nucleotide of the codon for amino acid residue 19 (nucleotide and amino acid numbering based on that reported previously) [16 ] , which was apparently linked to one of the two reported Fas gene polymorphisms, A416G [17] . Both of the two polymorphisms were located in the coding region, but were silent at the amino acid level. We found a strong association of Japanese SLE with the 297C/416G geno- DNA and RNA preparation total reaction volume of 5 ml. Reactions were conducted for 30 cycles consisting of 1 min at 95°C, 1 min at 55°C Peripheral blood mononuclear cells (PBMC ) were preand 2 min at 72°C. The PCR products were diluted with pared by Lymphocyte Separation Medium (LSMR) formamide dyes (95% formamide, 20 m Na 2 EDTA, (Organon Teknika Corp., Durham, NC, USA) from the 0.05% bromophenol blue and 0.05% xylene cyanol ) and heparinized blood of subjects. Total RNA and DNA heat denatured at 80°C for 5 min. They were then was prepared from the PBMC as described [19] . subjected to electrophoresis on 5% polyacrylamide gel
RT-PCR/SSCP analysis for the Fas gene
at 25°C with 5% glycerol, or at 4°C without glycerol at 13 V/cm, using 45 m Tris-borate and 1 m EDTA The primers used in the present study were synthesized buffer (pH 8.3). DNA fragments were visualized by on the basis of the nucleotide sequence of Fas cDNA exposing the gels to Fuji RX film (Fuji Photo Film Co., [16 ] and are listed in Table 1 . The schematic presentation Kanagawa, Japan). of Fas cDNA, along with the position of the primers, is shown in Fig. 1 . Fifty-seven out of the 82 SLE patients Sequencing analysis were studied using the RT-PCR/SSCP analysis. Total RNA was subjected to RT-PCR by using a GeneAmp Primers were labelled using T4 polynucleotide kinase (New England Biolabs, Inc., Beverly, MA, USA) and RNA PCR kit (Perkin Elmer, Norwalk, CT, USA). Briefly, 1 mg of total RNA was reverse transcribed
[c32P]ATP at 37°C for 20 min. For the analysis of the Fas gene, DNA fragments of interest were excised from to obtain cDNA in the presence of MoLV reverse transcriptase, oligo dT, and 25 m dNTP at 25°C the SSCP gels, purified on Suprec-01 ( Takara Shuzo Co., Otsu, Japan) and reamplified for 20 cycles confor 60 min in a total reaction mixture of 25 ml. PCR reactions were performed using 1 ml of the cDNA sisting of 1 min at 95°C and 2 min at 60°C by using 2 m of each primer, 200 m dNTP and 0. aThese two nucleotide sequences were previously designed by Cheng et al. [6] .
Sequence-specific oligonucleotide probe hybridization formed using mouse monoclonal IgM antibody against Fas (MBL, Nagoya, Japan). A sequence-specific oligonucleotide probe (SSOP) hybridization was performed to assess the frequency of Statistical analysis Fas polymorphisms in SLE patients and healthy conStatistical analysis was performed using the x2 test. trols. As shown in Fig. 2 Fig. 1 , TCTGG-3∞ for exon 2; 5∞-CTGTTCAAACACTTfour pairs of primers were used to amplify four overlap-GCTCCTT-3∞, 5∞-CCAAGATTGGCCTCTTTCAAT-3∞ ping regions of Fas cDNA (fragments A, B, C and D), for exon 3; 5∞-TCACATGCATTCTACAAGGCT-3∞, which covered the entire coding region of Fas along 5∞-GCAAGACTCCATCTCAAACAA-3∞ for exon 7. with the part of the 5∞ and 3∞ untranslated region of Fas The product sizes were 265, 213 and 269 bp, respectively.
cDNA. The product size of PCR was between 301 and PCR was performed for the Fas gene for 30 cycles of 358 bp. As the 3∞ primer for fragment B and the 5∞ 1 min at 95°C and 2 min at 60°C. Fifty nanograms of primer for fragment C were designed to locate in the amplified DNA in 2 ml were dot-blotted onto nylon filter transmembrane domain of the Fas gene, fragments B membranes, alkaline denatured with 0.4  NaOH, and and C detected only the transmembrane form. Among incubated at 54°C for 1 h with hybridization buffer 57 SLE patients, six (patients numbers 1, 4, 27, 38, 39 (50 m Tris-HCl, pH 8.0, 3  tetramethylammonium and 43) displayed aberrant bands in fragment A, and chloride, 2 m EDTA, 5 × Denhardt's solution, 0.1% five (patients numbers 3, 14, 16, 36 and 42) in fragment SDS, 100 mg/ml heat-denatured salmon sperm DNA) C, while none of the patients showed aberrant bands in containing 5-10 pmol of SSOP that was end-labelled by fragments B and D. As both of the bands detected in [c32P]ATP using T4 polynucleotide kinase. After rinsing fragment A of patient no. 4 migrated differently from with 2 × SSPE (0.3  NaCl, 0.02  sodium phosphate, those of healthy controls, this patient appeared to be 2 m EDTA, pH 7.4) containing 0.1% SDS at room homozygous for the variation. The other patients carried temperature, the filters were washed in TMAC solution two aberrantly migrated bands in addition to those (50 m Tris-HCl, pH 8.0, 3  tetramethylammonium found in healthy controls, suggesting the heterozygosity chloride, 2 m EDTA, 0.1% SDS) at room temperature for the variation. The aberrant bands were excised from for 10 min, followed by washing in TMAC solution at the SSCP gel and directly sequenced in their entirety. 58°C for 10 min twice. The filters were then subjected
The nucleotide sequence of the aberrant bands in fragto autoradiography. ment A was identical with that reported previously [16 ] , Analysis of Fas expression on freshly isolated PBMC except that nucleotide 297 was a C instead of a T ( T297C ), and nucleotide 416 was a G instead of an A The experimental procedure has been described previ-(A416G). In fragment C, the aberrantly migrated band ously [23] . The expression of Fas was studied by encoded the nucleotide sequence identical to that previFACScan. The immunofluorescence analysis was perously described except that nucleotide 836 was a T instead of a C (C836T ). These polymorphisms at nucleotides 297, 416 and 836 did not lead to amino acid substitution.
Association of 297C/416G Fas polymorphism with SLE
We next analysed the frequencies of the three polymorphisms in SLE patients and healthy controls. PCR amplification was performed with intron-based primers for exons 2, 3 and 7 for 82 SLE patients, followed by genotyping by SSOP analysis. As the polymorphisms 297C and 416G always existed simultaneously in the samples examined, both were considered to be located for the 297C/416G allele (data not shown). This is bThe numbers of controls studied were 132 for 297C/416G and 36 for 836T.
compatible with the finding that no significant defects could be detected in Fas expression or function in SLE patients [27] . Alternatively, it could be speculated that frequency in SLE patients was 6.7%. The 297C/416G allele was significantly frequent in SLE patients the mutation or polymorphism, linked to the 297C/416G genotype, may reside in the promoter or in the intron (P = 0.01, x2), with a relative risk of 5.00. The expression of Fas was not altered in the PBMC from the SLE region of the Fas gene, and that it modulates transcription or alternative splicing of the Fas message in a patient homozygous for the 297C/416G genotype (data not shown). No significant differences in clinical features particular condition or cell population. In fact, such polymorphisms have been reported in the promoter were observed between the patients with or without the 297C/416G allele. On the other hand, there was no region of the human Fas gene (−1377 nucleotide position in the silencer region and at −670 nucleotide significant difference in the frequency of the polymorphisms at nucleotide 836 ( Table 2) . position in the enhancer region) [28] . The former polymorphism resides in the binding site sequence of transcription factor SP-1, and the latter occurs in the binding Discussion site of the nuclear transcription element GAS. It is also probable that polymorphism(s) in the intron may affect SLE is a polygeneic autoimmune disorder affecting multiple organ systems. Genetic predisposition to SLE the alternative splicing of the Fas gene, considering that at least five forms of soluble Fas molecules have been has been linked to genes located within major histocompatibility complex (MHC ) class II (DR, DQ) and class reported to be generated by alternative splicing and to prevent Fas-mediated apoptosis [29] . The association of III (C2, C4, TNF ) on chromosome 6 [24] . Of these factors, the C4 null allele, especially C4A (C4AQ0), has silent polymorphism in the coding region with a human disease is not unprecedented. For example, 5-HT 2A been shown to be the strongest correlate among different ethnic groups [25] . Individuals with a deficiency of the receptor polymorphism was implicated in the pathogenesis and pharmacotherapy of schizophrenia by a other class III complement gene, C2, are also at increased risk for SLE. The precise mechanism by which large-scale multicentre study in Europe ( European Multicentre Association Study of Schizophrenia Group) these complement deficiencies contribute to the pathogenesis of SLE is unclear; however, there are explan- [30] . The T to C transition at nucleotide 102 ( T102C ) in the coding region of the 5-HT 2A receptor did not ations, such as a disturbance of immune complex clearance, the increased risk of pathogens causing an alter amino acid sequence or the steady-state expression of the 5-HT 2A receptor [31] . autoimmune response, or the linkage disequilibrium with the other MHC genes. Associations between DR2
Although a large-scale study in SLE patients, as well as in patients with autoimmune diseases other than SLE, or DR3 and susceptibility to SLE have also been noted in various ethnic groups [26 ] . It is suggested that the is still needed, the 297C/416G polymorphism in the Fas gene or a neighbouring genetic abnormality may serve antigen for autoimmune response is presented by the critical amino acids in the DR region. Recent studies in as a candidate for the pathogenesis of SLE. both animal models and other human autoimmune diseases also suggest that non-MHC genes contribute to
